Literature DB >> 1515262

Axillary dissection of level I and II lymph nodes is important in breast cancer classification. The Danish Breast Cancer Cooperative Group (DBCG).

C K Axelsson1, H T Mouridsen, K Zedeler.   

Abstract

In order to define the term "a node-negative patient", the axillary nodal status at the primary operation for breast cancer was evaluated in 13,851 patients registered by the Danish Breast Cancer Cooperative Group (DBCG). The determinants for node negativity in primary breast cancer were the number of lymph nodes removed and the tumour size. The number of lymph nodes removed should be at least 10 to exclude misclassification of node-positive patients as node negative. There was a strong relationship between tumour size and the percentage of node-negative patients. Another observation was that high rate of node negativity was associated with low histological grade. The age of the patients had no influence on node negativity. Where 10 or more negative lymph nodes were removed, significantly better axillary recurrence-free survival (P less than 0.0001), over-all recurrence-free survival (P less than 0.0001) and survival (P less than 0.005) were found.

Entities:  

Mesh:

Year:  1992        PMID: 1515262     DOI: 10.1016/0959-8049(92)90534-9

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  38 in total

Review 1.  Axillary staging of breast cancer and the sentinel node.

Authors:  G Cserni
Journal:  J Clin Pathol       Date:  2000-10       Impact factor: 3.411

Review 2.  Is axillary lymph node clearance required in node-positive breast cancer?

Authors:  Nigel J Bundred; Nicola L P Barnes; Emiel Rutgers; Mila Donker
Journal:  Nat Rev Clin Oncol       Date:  2014-11-04       Impact factor: 66.675

3.  Lymph node ratio is more valuable than level III involvement for prediction of outcome in node-positive breast carcinoma patients.

Authors:  Emin Yildirim; Ugur Berberoglu
Journal:  World J Surg       Date:  2007-02       Impact factor: 3.352

4. 

Authors:  P Schäfer
Journal:  Arch Gynecol Obstet       Date:  1995-12       Impact factor: 2.344

5. 

Authors:  J C Rageth
Journal:  Arch Gynecol Obstet       Date:  1995-12       Impact factor: 2.344

6.  A survey of the management of breast cancer in England and Wales.

Authors:  S A Harries; R N Lawrence; R Scrivener; N R Fieldman; M W Kissin
Journal:  Ann R Coll Surg Engl       Date:  1996-05       Impact factor: 1.891

7.  Utility of Ultrasound and Mammography in Detection of Negative Axillary Nodal Metastasis in Breast Cancer.

Authors:  Anam Khan; Imrana Masroor; Kumail Khandwala; Summar-Un-Nisa Abbasi; Muhammad Usman Tariq
Journal:  Cureus       Date:  2020-01-17

8.  Clinical practice guidelines for the care and treatment of breast cancer: 16. Locoregional post-mastectomy radiotherapy.

Authors:  Pauline T Truong; Ivo A Olivotto; Timothy J Whelan; Mark Levine
Journal:  CMAJ       Date:  2004-04-13       Impact factor: 8.262

Review 9.  Breast cancer (non-metastatic).

Authors:  Justin Stebbing; Geoff Delaney; Alistair Thompson
Journal:  BMJ Clin Evid       Date:  2007-12-04

10.  Axillary lymph node dissection in node-positive breast cancer: are ten nodes adequate and when is enough, enough?

Authors:  Laura H Rosenberger; Yi Ren; Samantha M Thomas; Rachel A Greenup; Oluwadamilola M Fayanju; E Shelley Hwang; Jennifer K Plichta
Journal:  Breast Cancer Res Treat       Date:  2019-11-18       Impact factor: 4.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.